远处转移性恶性肿瘤的临床试验
总计12907个结果
-
Daiichi SankyoAstraZeneca招聘中
-
Memorial Sloan Kettering Cancer CenterRepare Therapeutics招聘中
-
Imperial College LondonCuresponse Ltd.尚未招聘
-
Meryx, Inc.主动,不招人
-
Samsung Medical Center完全的
-
P.O. WitteveenErasmus Medical Center; The Netherlands Cancer Institute终止
-
Virginia Commonwealth University终止
-
Tata Medical Center完全的III期口咽部恶性肿瘤 | 喉部恶性肿瘤 III 期 | 下咽恶性肿瘤Ⅲ期 | IVa期口咽部恶性肿瘤 | IVb期口咽部恶性肿瘤 | 喉恶性肿瘤IV期 | 下咽恶性肿瘤IVa期 | 下咽恶性肿瘤IVb期印度
-
National Cancer Institute (NCI)主动,不招人转移性黑色素瘤 | IV 期皮肤黑色素瘤 AJCC v6 和 v7 | 难治性恶性实体瘤 | 不可切除的恶性实体肿瘤美国
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City完全的
-
Peking Union Medical College Hospital完全的
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
Case Comprehensive Cancer Center尚未招聘
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Grupo Espanol Multidisciplinario del Cancer Digestivo招聘中
-
Tracon Pharmaceuticals Inc.主动,不招人
-
National Cancer Institute (NCI)撤销
-
Jonsson Comprehensive Cancer CenterMedivation, Inc.; BioMarin Pharmaceutical; Translational Research in Oncology完全的
-
Dr. Ronnie Shapira尚未招聘转移性黑色素瘤 | 恶性黑色素瘤 | 免疫疗法 | 恶性黑色素瘤 IV 期 | BRAF V600E
-
Oslo University HospitalHelse Sor-Ost主动,不招人
-
The Belgian Society of Medical OncologyRoche Pharma AG; Foundation Medicine; Sciensano招聘中
-
BeiGene招聘中乳腺癌 | 转移性乳腺癌 | 晚期实体瘤 | 转移性实体瘤 | 激素受体阳性乳腺恶性肿瘤 | HER2 阴性乳腺癌 | 激素受体阳性乳腺癌中国
-
Arjun MittraNational Cancer Institute (NCI)招聘中
-
David BartlettNational Cancer Institute (NCI)完全的
-
University Hospital, Basel, Switzerland尚未招聘
-
Cristal Therapeutics完全的
-
First Affiliated Hospital of Fujian Medical University招聘中